PTSM: Pharmaceutical Technology Sourcing and Management, Apr 4, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Apr 4, 2012
Biologics
Manufacturing Capacity-Sharing Model: Merck & Co. and MedImmune LLC
By Patricia Van Arnum
The manufacturing capacity-sharing model in biologics between Merck & Co. and MedImmune LLC ushers in a new paradigm of co-opetition.
APIs
Pharmaceutical Industry Faces Compulsory Licensing in India
By Patricia Van Arnum
The decision by the Indian patent authorities to issue a compulsory license for a generic version of a Bayer anticancer drug engenders debate.
Outsourcing
CMOs Face a Kodak Moment
By Jim Miller
The evolving bio/pharmaceutical business model poses risk for CMOs.
CSR and Sustainability Forum
UN Launches Commission on Life-Saving Commodities for Women and Children
By Patricia Van Arnum
A new UN organization focuses on improving the delivery of essential health supplies, promoting new technologies and products, strengthening regulatory frameworks, and enhancing financing mechanisms.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here